Substituted chromanol derivatives and their use

US8227511B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Carsten Schmeck · Wuppertal, DE
• Hilmar Bischoff · Wuppertal, DE
• Volkhart Min-Jian Li · Velbert, DE
• Klemens Lustig · Wuppertal, DE
• Michael Thutewohl · Buchs, CH
• Alexandros Vakalopoulos · Hilden, DE
• Olaf Weber · Wülfrath, DE

Key dates

• Filing date: Mar 7, 2007
• Grant date: Jul 24, 2012
• Expiry date: Nov 19, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D311/96
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to substituted chromanol derivatives, to processes for their preparation, to their use on their own or in combination for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders.